过度
发表于 2025-3-26 22:09:49
http://reply.papertrans.cn/27/2651/265015/265015_31.png
陈列
发表于 2025-3-27 04:49:55
Bernd Guggenberger,Klaus Hansenrine, serotonin, acetylcholine, and glutamate systems. Loss of these transmitter systems initiates a cascade of neurological deficits beginning with motor function and ending with dementia. Current therapies primarily address the motor symptoms of the disease via dopamine replacement therapy. Exogen
临时抱佛脚
发表于 2025-3-27 06:46:28
Bernd Guggenberger,Klaus Hansenuch as stroke and Parkinson’s Disease. In particular, delta opioid receptors (DORs) have been elucidated as a therapeutically distinguished subset of opioid receptors and a compelling target for novel intervention techniques. Research is progressively shedding light on the underlying mechanism of DO
vocation
发表于 2025-3-27 13:02:24
http://reply.papertrans.cn/27/2651/265015/265015_34.png
粘连
发表于 2025-3-27 15:32:38
Auf der Suche nach der neuen Mitteas pain or itch, and unfavorable cosmetic outcomes. Moreover, some wounds simply fail to heal and become a chronic burden for the sufferer. Understanding the mechanisms underlying wound healing and the concomitant sensory disorders and how they might be manipulated for therapeutic benefit has attrac
peptic-ulcer
发表于 2025-3-27 21:24:31
http://reply.papertrans.cn/27/2651/265015/265015_36.png
intrigue
发表于 2025-3-28 01:05:00
Delta Opioid Receptor Pharmacology and Therapeutic Applications
动作谜
发表于 2025-3-28 03:06:20
Delta Opioid Receptor (DOR) Ligands and Pharmacology: Development of Indolo- and Quinolinomorphinannt agonist activity following systemic administration. Interestingly, KNT-127 produced no convulsive effects, unlike prototype DOR agonists. The KNT-127 type derivatives with a quinolinomorphinan structure are expected to be promising candidates for the development of therapeutic DOR agonists.
类似思想
发表于 2025-3-28 07:30:16
http://reply.papertrans.cn/27/2651/265015/265015_39.png
Mast-Cell
发表于 2025-3-28 12:36:54
http://reply.papertrans.cn/27/2651/265015/265015_40.png